Aberrant expression of 12‐LOX and increased production of its metabolite 12‐HETE have been extensively studied in several malignancies, including prostate [93], ovarian [94], and melanoma [95], where they stimulate cancer progression and metastasis (recently reviewed in Ref. Here, ALOX15 is linked to cancer.